UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Lymphoma Studies

For patients infected with HIV and lymphoma, the UCLA CARE Center has studies available.

AMC 075

Study examining if vorinostat may improve the effectiveness of chemotherapy in patients with HIV and non-Hodgkin lymphoma.

AMC 080

Study examining the risks and benefits of allogeneic stem cell transplant for men and women with acute myeloid leukemia (AML) or acute lymphocytic leukemia (ALL) in first or second remission (CR) and HIV infection.

AMC 083

Tissue collection study to examine outcomes, immune response and progression of various malignancies in association with HIV.  Individuals with diffuse large B-cell lymphoma, non small-cell lung malignancy, anal or cervical cancer may be eligible to participate.

AMC 085

A pilot trial of AVD in addition to Brentuximab Vedotin (SGN-35) in the treatment of state II-IV HIV associated Hodgkin Lymphoma.

AMC 086

Phase II study of dose-adjusted EPOCH+/- Rituximab in adults with untreated Burkitt Lymphoma, Myc positive diffuse large B-cell Lymphoma, and Plasmablastic Lymphoma.

 AMC 091

Ibrutinib in treating relapsed or refractory B-cell Non-Hodgkin Lymphoma in patients with HIV infection

 

For more information about the UCLA CARE Center's clinical trials and research studies, please contact:
Phone:  (310) 557-9062
Email:  CAREOutreach@mednet.ucla.edu